Compare

Two peptides, one row at a time.

Pick any two indexed peptides. The URL captures your selection - paste it in a deck, an email, a paper. The view stays the same for any reader who opens it.

Identity
  • Sequence
    KCNTATCATNRLANFLVRSSNNLGPVLPPTNVGSNTY
    GEPPPGKPADDAGLV
  • Length
    37 aa
    15 aa
  • Molecular weight
    3890.40
    1419.55
  • Modifications
    disulfide C2-C7γGlu-C18 lipid sidechainamidated C-terminus
    acetyl-N-terminus
  • Mechanism

    Long-acting amylin analog; suppresses appetite and gastric emptying. In Phase 3 as CagriSema combination with semaglutide.

    Pentadecapeptide derived from human gastric juice; modulates VEGF and growth-hormone receptor expression in injured tissue.

Provenance
  • BioGate
    verifiedBioGate · GREEN
    verifiedBioGate · GREEN
  • PDA-V1 outer
  • Inputs hash
  • Model version
    structure-fm-2026.04
    structure-fm-2026.04
  • PDA candidates
    2
    4
Outcomes
  • RWE cohorts
    1
    5
  • Total participants
    216
    270
  • Primary endpoint Δ
    +2.32 Δ HRV ms (8-week)
    95% CI [0.8, 3.83]
    -1.7 Δ HRV ms (8-week)
    95% CI [-2.46, -0.94]
  • LOO posterior
    39.3%
    β(35.1, 54.2)
    88.1%
    β(33.8, 4.6)
  • Top-grade citations
    Grade B1 of 1
    Grade B2 of 2
Economics
  • IPNFT
    Molecule IPNFT V2
    Solana · 115 holders
    Molecule IPNFT V2
    Solana · 73 holders
  • Royalty cascade
    4.07%
    10.04%
Indications
  • Listed indications
    • · obesity (combination with semaglutide)
    • · weight management
    • · soft-tissue recovery
    • · GI mucosal repair
    • · tendon healing